We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+16.38%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$1.46B
AUM Growth
+$222M
Cap. Flow
+$49.8M
Cap. Flow %
3.4%
Top 10 Hldgs %
67.23%
Holding
266
New
5
Increased
172
Reduced
10
Closed
8

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$167M
2
AMZN icon
Amazon
AMZN
+$5.51M
3
ABT icon
Abbott
ABT
+$4.26M
4
AGN
Allergan plc
AGN
+$2.31M
5
XYZ
Block Inc
XYZ
+$2.26M

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$1.73M
2
ADT
ADT Corp
ADT
+$915K
3
SDS icon
ProShares UltraShort S&P500
SDS
+$791K
4
KMI icon
Kinder Morgan
KMI
+$550K
5
MO icon
Altria Group
MO
+$425K

Sector Composition

Rank Sector Weight
1 Healthcare 58.41%
2 Energy 12.88%
3 Utilities 5.3%
4 Consumer Staples 4.25%
5 Communication Services 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MPC icon
201
Marathon Petroleum
MPC
$91.4B
$85K 0.01%
2,234
– –
OLN icon
202
Olin
OLN
$2.08B
$77K 0.01%
3,109
+26
+0.8% +$561
WIN
203
DELISTED
Windstream Holdings Inc
WIN
$77K 0.01%
1,662
– –
IWM icon
204
iShares Russell 2000 ETF
IWM
$79.8B
$76K 0.01%
661
– –
MON
205
DELISTED
Monsanto Co
MON
$75K 0.01%
722
– –
ENLK
206
DELISTED
EnLink Midstream Partners, LP
ENLK
$70K ﹤0.01%
4,204
– –
IBB icon
207
iShares Biotechnology ETF
IBB
$9.3B
$53K ﹤0.01%
615
– –
PNR icon
208
Pentair
PNR
$10.4B
$51K ﹤0.01%
1,300
+5
+0.4% +$194
CELG
209
DELISTED
Celgene Corp
CELG
$47K ﹤0.01%
476
– –
AVNS
210
DELISTED
Avanos Medical
AVNS
$42K ﹤0.01%
1,303
– –
VOD icon
211
Vodafone
VOD
$36.5B
$41K ﹤0.01%
1,332
– –
TGP
212
DELISTED
Teekay LNG Partners L.P.
TGP
$40K ﹤0.01%
3,593
-3,855
-52% -$50.3K
COR icon
213
Cencora
COR
$60.7B
$35K ﹤0.01%
435
+2
+0.5% +$160
XLU icon
214
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
$35K ﹤0.01%
1,352
+12
+0.9% +$296
NOV icon
215
NOV
NOV
$6.84B
$34K ﹤0.01%
1,018
– –
VEA icon
216
Vanguard FTSE Developed Markets ETF
VEA
$229B
$34K ﹤0.01%
953
+13
+1% +$470
GOOGL icon
217
Alphabet (Google) Class A
GOOGL
$4.32T
$32K ﹤0.01%
900
– –
GOOG icon
218
Alphabet (Google) Class C
GOOG
$4.32T
$31K ﹤0.01%
900
– –
IGM icon
219
iShares Expanded Tech Sector ETF
IGM
$10B
$31K ﹤0.01%
1,710
+6
+0.4% +$110
ENBL
220
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$31K ﹤0.01%
2,307
+60
+3% +$745
TMO icon
221
Thermo Fisher Scientific
TMO
$212B
$30K ﹤0.01%
202
+1
+0.5% +$148
XLB icon
222
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
$28K ﹤0.01%
1,208
+6
+0.5% +$140
STCN
223
DELISTED
Steel Connect, Inc. Common Stock
STCN
$28K ﹤0.01%
2,481
– –
DAL icon
224
Delta Air Lines
DAL
$58.1B
$27K ﹤0.01%
750
– –
XLF icon
225
State Street Financial Select Sector SPDR ETF
XLF
$56.9B
$24K ﹤0.01%
1,185
+6
+0.5% +$121
7 8
9
10 11

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return

Bollard Group's Q2 2016 Portfolio in Review

As of Q2 2016, Bollard Group held 266 positions worth $1.46B, up 18% from $1.24B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bollard Group deployed $49.8M of net new capital in Q2 2016, opening 5 new positions and adding to 172 existing holdings. Its largest new stake was Allergan plc: 10,000 shares worth $2.31M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 44% a quarter earlier, followed by Energy and Utilities.

On the sell side, the largest reduction was ProShares Short S&P500, an estimated $1.73M trimmed.

  • Bollard Group's largest Q2 2016 buy was Allergan plc: 10,000 shares worth $2.31M.
  • Bollard Group added most to Boston Scientific in Q2 2016, an estimated $167M increase.
  • Bollard Group's biggest Q2 2016 reduction was ProShares Short S&P500, cutting an estimated $1.73M.
  • Bollard Group fully exited ADT Corp in Q2 2016, selling an estimated $915K.
  • Bollard Group's ten largest holdings make up 67% of its $1.46B portfolio in Q2 2016.
  • Bollard Group opened 5 new positions and closed 8 in Q2 2016.
  • Bollard Group's portfolio value rose 18% quarter-over-quarter to $1.46B.

Based on Bollard Group's 13F filing for Q2 2016, filed 20 Jul 2016.